BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11836594)

  • 1. Prognostic significance of a combination of thymidylate synthase and dihydropyrimidine dehydrogenase activities in grades 1 and 2 superficial bladder cancer.
    Mizutani Y; Wada H; Yoshida O; Fukushima M; Bonavida B; Kawauchi A; Miki T
    Oncol Rep; 2002; 9(2):289-92. PubMed ID: 11836594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidylate synthetase and dihydropyrimidine dehydrogenase levels in gastric cancer.
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Takechi T; Okabe H; Fukushima M; Kitajima M
    Anticancer Res; 1999; 19(6C):5635-40. PubMed ID: 10697632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activities of thymidylate synthase and dihydropyrimidine dehydrogenase in patients with colorectal cancer].
    Uehara M; Takahashi S; Takenaka A; Izumi H; Fujii K; Ikawa O; Miyata K; Iizuka R; Matsumura H; Kakihara N; Shono Y; Tsuchihashi H; Saisaka Y
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):2035-41. PubMed ID: 11791381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer.
    Terashima M; Irinoda T; Fujiwara H; Nakaya T; Takagane A; Abe K; Yonezawa H; Oyama K; Inaba T; Saito K; Takechi T; Fukushima M
    Anticancer Res; 2002; 22(2A):761-8. PubMed ID: 12014648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers.
    Baba H; Teramoto K; Kawamura T; Mori A; Imamura M; Arii S
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):469-76. PubMed ID: 13680162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma.
    Mizutani Y; Wada H; Fukushima M; Yoshida O; Nakanishi H; Li YN; Miki T
    Cancer; 2004 Feb; 100(4):723-31. PubMed ID: 14770427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of thymidylate synthase expression in patients with prostate cancer undergoing radical prostatectomy.
    Li Y; Mizutani Y; Shiraishi T; Okihara K; Ukimura O; Kawauchi A; Nonomura N; Fukushima M; Sakai T; Miki T
    Urology; 2007 May; 69(5):988-95. PubMed ID: 17482957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
    Miyoshi T; Kondo K; Fujino H; Takahashi Y; Sawada N; Sakiyama S; Tsuyuguchi M; Kimura S; Sumitomo M; Monden Y
    Anticancer Res; 2005; 25(2A):923-30. PubMed ID: 15868929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of thymidylate synthase activity in bladder carcinoma.
    Mizutani Y; Wada H; Ogawa O; Yoshida O; Fukushima M; Nonomura N; Miki T
    Cancer; 2001 Aug; 92(3):510-8. PubMed ID: 11505394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy.
    Jakob C; Liersch T; Meyer W; Baretton GB; Schwabe W; Häusler P; Kulle B; Becker H; Aust DE
    Am J Surg Pathol; 2006 Sep; 30(9):1169-74. PubMed ID: 16931962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy.
    Huang CL; Yokomise H; Kobayashi S; Fukushima M; Hitomi S; Wada H
    Int J Oncol; 2000 Jul; 17(1):47-54. PubMed ID: 10853017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressions of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase in breast cancer and their correlations with prognosis].
    Li HX; Zh S; Zhang YH; Risberg B; Karlsson MG; Nesland JM
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):669-72. PubMed ID: 15777505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of thymidine kinase activity in bladder carcinoma.
    Mizutani Y; Wada H; Yoshida O; Fukushima M; Kamoi K; Miki T
    Cancer; 2002 Nov; 95(10):2120-5. PubMed ID: 12412165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic predictors in breast cancer patients with postoperative 5-fluorouracil-based chemotherapy.
    Hakamada Y; Tsuchida A; Arima M; Kubouchi T; Tokita H; Ota D; Kaise H; Aoki T; Kusama M; Aoki T
    Int J Mol Med; 2005 Aug; 16(2):309-14. PubMed ID: 16012767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase and dihydropyrimidine dehydrogenase expressions in gallbladder cancer.
    Ajiki T; Hirata K; Okazaki T; Horiuchi H; Fujita T; Habara K; Kamigaki T; Suzuki Y; Kuroda Y
    Anticancer Res; 2006; 26(2B):1391-6. PubMed ID: 16619549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of two fluorouracil administration regimens for colorectal cancer.
    Matsusaka S; Yamasaki H; Kitayama Y; Okada T; Maeda S
    Oncol Rep; 2003; 10(1):109-13. PubMed ID: 12469154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dihydropyrimidine dehydrogenase and thymidylate synthase in colon carcinoma].
    Hamaji M; Nishida T; Miyazaki S; Nishida Y
    Gan To Kagaku Ryoho; 2002 Jun; 29(6):889-93. PubMed ID: 12090040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.